Dishman Carbogen Amcis Ltd.

NSE: DCAL | BSE: 540701

₹187.92

up-down-arrow3.55 (1.93%)

As on 09-Jun-2026 15:57IST

Market cap

info icon

₹2,958 Cr

Revenue (TTM)

info icon

₹2,932 Cr

P/E Ratio

info icon

30.4

P/B Ratio

info icon

0.4

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score1/10

Growth Score fund-quick-summary-circle

Growth Score5/10

Valuation Score fund-quick-summary-circle

Valuation Score5/10

Momentum Score fund-quick-summary-circle

Momentum Score4/10

Dishman Carbogen Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 180.20 High: 189.90

52 Week Range

Low: 128.50 High: 321.95

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹97 Cr

  • ROEROE information

    0.1 %

  • ROCEROCE information

    2.3 %

  • Industry P/EIndustry P/E information

    277.96

  • EV/EBITDAEV/EBITDA information

    7.6

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹425.9

  • EPSEPS information

    ₹6.4

  • Face valueFace value information

    2

  • Shares outstandingShares outstanding information

    156,783,095

10 Years Aggregate

CFO

₹3,286.95 Cr

EBITDA

₹3,578.22 Cr

Net Profit

₹342.60 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Dishman Carbogen
-24.1 0.4 14.4 -29.9 14.0 -3.0 --
BSE Healthcare
8.7 1.4 8.4 9.2 24.9 13.5 12.2
As on 09-Jun-2026
Company
2025
2024
2023
2022
2021
2020
2019
Dishman Carbogen
-13.2 51.1 80.1 -52.9 41.8 76.7 -63.8
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Dishman Carbogen
187.9 2,957.7 2,931.9 97.5 7.7 1.5 30.4 0.4
17.5 74.9 44.6 -16.6 -- 0 -- --
27.3 8.3 0.3 0.0 15.7 0.8 278 2.1
523.4 12,643.7 3,510.5 401.1 14.0 13.9 31.5 4.0
70.1 249.2 128.4 -10.4 -9.4 -10.4 -- 2.7
252.8 11,444.7 2,950.9 420.1 17.0 14.6 27.4 3.8
1,229.7 26,090.2 2,192.5 348.9 21.2 14.9 74.8 10.5
4,713.3 10,813.0 935.0 257.9 34.3 78.9 41.9 23.9
29.6 440.1 54.2 10.9 -4.1 13.9 40.6 14.2
24.5 53.8 53.3 -1.7 20.3 -14.9 -- 0.6

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Dishman Carbogen

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules...  segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP. 

  • Incorporated

    2007

  • Chairman

    --

  • Managing Director

    Arpit J Vyas

  • Group

    Dishman Pharma

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.dishmangroup.com

Edit peer-selector-edit

FAQs for Dishman Carbogen

The share price of Dishman Carbogen Amcis Ltd is ₹187.92 (NSE) and ₹188.75 (BSE) as of 09-Jun-2026 15:57 IST. Dishman Carbogen Amcis Ltd has given a return of 13.98% in the last 3 years.

The P/E ratio of Dishman Carbogen Amcis Ltd is 30.35 times as on 09-Jun-2026, a 89 discount to its peers’ median range of 277.96 times.
The P/B ratio of Dishman Carbogen Amcis Ltd is 0.44 times as on 09-Jun-2026, a 79 discount to its peers’ median range of 2.12 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
1,053.24
0.59
2024
0.00
0.66
2023
0.00
0.34
2022
161.20
0.52
2021
0.00
0.30

The 52-week high and low of Dishman Carbogen Amcis Ltd are Rs 321.95 and Rs 128.50 as of 09-Jun-2026.

Dishman Carbogen Amcis Ltd has a market capitalisation of ₹ 2,958 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Dishman Carbogen Amcis Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.